Ads
related to: monoclonal antibody treatment
Search results
A Guide to Managing COVID This Summer
New York Times· 2 days agoHere’s what to know about symptoms, testing and treatment. As new variants of the coronavirus continue to gain traction, doctors and researchers are...
Adagene Inc. (NASDAQ:ADAG) Sees Large Decline in Short Interest
ETF DAILY NEWS· 14 hours agoAdagene Inc. (NASDAQ:ADAG – Get Free Report) was the target of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 2,700 shares, a drop ...
RSV research: Nirsevimab 80% effective against hospitalization
Center for Infectious Disease Research and Policy· 7 days agoTwo studies highlight new respiratory syncytial virus (RSV) findings, with one estimating that the ...
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 13 hours agoTRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday. Separately ...
US FDA advisers to review Eli Lilly Alzheimer's drug
Reuters· 4 days agoBoth drugs are designed to remove toxic beta amyloid plaques from the brains of people with early Alzheimer's disease. The antibody treatments, which...
A Guide to Managing COVID This Summer
The New York Times via Yahoo News· 2 days agoTwo of these variants, KP.3 and KP.2, now account for nearly half of all cases, and data from the Centers for Disease Control and Prevention shows a...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
Ultragenyx (RARE) Posts New Data From Bone Disease Study
Zacks via Yahoo Finance· 2 days agoUltragenyx's (RARE) pipeline candidate setrusumab shows sustained reductions in fracture rates in...
Campbell & CO Investment Adviser LLC Invests $562,000 in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB)
ETF DAILY NEWS· 5 days agoCampbell & CO Investment Adviser LLC purchased a new stake in shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional ...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
AOL· 1 day agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of blockbuster arthritis drug Humira following the entry of biosimilars in the U.S. The drugmaker ...
